HT recipients transplanted over a recent 15-year period at currently active US pediatric HT centers. Our specific aims were (1) to test the hypothesis that there are significant differences in riskadjusted posttransplant patient and graft survival among centers and (2) to evaluate the association of 3 center characteristicscenter-volume, center case-mix, and center-performance for short-term posttransplant outcomes-with longer-term survival differences. We assessed center case-mix by estimating expected 90-day mortality at each center based on patient characteristics at HT using an internally developed and validated risk-assessment model. We assessed center performance for short-term posttransplant outcomes by calculating standardized mortality ratio (SMR) for 90-day mortality for each center.
| MATERIAL S AND ME THODS

| Study subjects
We identified all children <18 years of age in the OPTN database who received their first HT in the United States between January 1, 2000 and December 31, 2014 at currently active pediatric HT centers defined as centers that performed at least 1 pediatric HT during 2013-2014. Children who received heart retransplantation or multiorgan transplantation were excluded. We excluded centers that 
| Study design and definitions
This was a retrospective cohort study. Two primary endpointsposttransplant death and posttransplant graft loss (death or retransplant)-were analyzed.
Demographic and clinical variables were defined at the time of transplant. Race/ethnicity was recorded as reported by the HT center and analyzed as White (non-Hispanic White), Black (non-Hispanic Black), Hispanic, or Other. Renal function was analyzed as estimated glomerular filtration rate (GFR, in mL/min per 1.73 m 2 ) using serum creatinine and the modified Schwartz equation. 4 For children ≥1 year of age, normal renal function was defined as GFR >60, moderate dysfunction as GFR 30-60, and severe dysfunction as GFR <30
or dialysis support. For infants <1 year of age, normal renal function was defined as GFR >40, moderate dysfunction as GFR 20-40, and severe dysfunction as GFR <20 or dialysis support. 
| Statistical analysis
Baseline characteristics are presented as median (25th, 75th percentile) or number (percent). We compared baseline characteristics among HT recipients transplanted at centers stratified by annual transplant volume (<4, 4-7.9, 8-11.9, and ≥12/year) using the χ 2 test
for categorical and the Kruskal-Wallis test for continuous variables.
Patient and graft survival and unadjusted survival by era were assessed using Kaplan-Meier survival curves.
To evaluate risk factors associated with posttransplant mortality, we developed a multivariable Cox regression model using forward selection retaining variables significant at the 0.10 level based on a likelihood ratio test; all patient variables are shown in Table 1 . A similar model was developed for posttransplant graft loss (death or retransplantation), retaining all variables that were include in the Cox model for mortality. We adjusted all models for the calendar year of HT due to the known improvement in early posttransplant survival over time. 7, 8 To assess center differences in outcomes, risk factors identified were then included in a mixed-effects Weibull survival model with center as a random effect ("mestreg" function in Stata).
Random effects were assumed to follow a normal distribution with a mean of 0. Random effect for a center corresponds to the deviation of the center from the overall baseline risk. The significance of the random effect was evaluated using a likelihood ratio test comparing models with and without the random effect. A risk-adjusted hazard ratio (HR) with 95% confidence interval (CI) was calculated for each center.
To evaluate the association of center case-mix and center performance for short-term posttransplant outcomes with center differences in longer-term survival, we used logistic regression to develop a risk-assessment model for 90-day posttransplant mortality using forward selection, patient characteristics at HT, and the transplant year. Model discrimination was assessed using the area under the receiver-operating characteristic curve (C statistic) and calibration using the Hosmer-Lemeshow goodness-of-fit test. The model was internally validated using bootstrapping (100 random samples, 4271 children/sample with replacement). This model was then used to estimate the probability of death within 90 days for each recipient, the expected 90-day mortality for each center (a measure of case-mix), and the standardized mortality ratio (SMR, observed 90-day mortality divided by expected 90-day mortality, lower SMR in centers with better risk-adjusted outcomes) for each center. Centers were ranked based on case-mix severity and grouped into quartiles with increasing rank. Centers were separately ranked based on SMR and grouped into quartiles with increasing rank. The contribution of center volume (4 groups), center case-mix (quartiles), and center SMR (quartiles) in explaining center effect on posttransplant patient and graft survival was assessed by adding these variables to the mixed-effects Weibull survival model and evaluating whether center effect/differences persisted. The effect of these characteristics was analyzed for patient follow-up censored at 5 years posttransplant and for overall follow-up.
Data were analyzed using SAS version 9.4 (SAS Institute, Inc., Cary, NC) and Stata version 14 (StataCorp, College Station, TX). All statistical tests were 2-sided and a P value <.05 defined statistical significance. The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the manuscript as written.
| RE SULTS
During the 15-year study period, 4663 children <18 years of age Table 1 . HT recipients at low-volume centers (<4 transplants/y) were less likely to be infants or have a diagnosis of congenital heart disease. They were more likely to be of black race, have dilated cardiomyopathy, and have Medicaid insurance.
| Center effect on posttransplant outcomes
Median posttransplant follow-up in study children was 4.1 years.
Overall, 1019 children died and 192 underwent retransplantation ( Figure S1 ). Overall 1-, 3-, and 5-year patient survival was 90%, 84%, and 79%, respectively. Overall patient survival improved with time ( Figure S2) . A multivariable Cox model of posttransplant death and a
Cox model of graft loss (death or retransplant) are shown in Table 2 .
Baseline patient variables associated with risk of death and graft loss were black race, complexity of cardiac diagnosis, level of hemodynamic support, renal dysfunction, higher serum bilirubin, and earlier year of transplant. In addition, female sex was also associated with risk of graft loss.
Center-specific 3-year patient survival varied from 66% to 100% and 5-year survival from 61% to 100%. Figure 1 illustrates risk-adjusted center effect for death ( Figure 1A ) and graft loss ( Figure 1B) Figure 1A ), there was a significant difference among centers for risk of mortality (P = .01).
Center effect was stronger and more noticeable for risk-adjusted graft loss (P < .001), where 3 centers had significantly superior or inferior performance ( Figure 1B ). Of note, limiting the analysis to a recent 3-year cohort (rather than 15-year study cohort) demonstrated no center difference in risk of patient mortality (P = .29) or graft loss (P = .21).
| Case-mix severity and center performance for early posttransplant outcomes
The model for 90-day posttransplant mortality generated from the study cohort (Table 3) 
| D ISCUSS I ON
This study has 3 major findings. First, there are significant differences in posttransplant patient and graft survival among currently active pediatric HT centers in the United States. These differences are more pronounced for graft survival than for patient survival, probably due to a higher frequency of events when analyzing graft survival. Second, center differences in short-term performance (90-day SMR) and in annual transplant volume explain and contribute to center differences in patient and graft survival to a significant degree, whereas center case-mix is not associated. Third, the survival This is the first study to investigate center effect on posttransplant outcomes in pediatric heart transplantation and to evaluate center attributes other than transplant volume. Although our results
showed statistically significant center effect on patient and graft survival, the confidence intervals for risk-adjusted outcomes at individual centers were wide and for most centers included 1 (Figure 1) , which is likely due to a large number of centers each with a relatively small number of outcome events. Thus, the answer to the question "are risk-adjusted outcomes different among pediatric centers?" is different from "are there a number of centers with significantly F I G U R E 1 Posttransplant outcomes for 46 currently active pediatric heart transplant centers expressed as risk-adjusted hazard ratios with 95% confidence intervals for death (A) and graft loss (B). The P values were derived using mixed-effects survival models with and without center as a random effect and show a significant center effect for risk of posttransplant mortality and graft loss 
| Modeling center case-mix and SMR
We chose a 90-day model to evaluate center case-mix and center SMR, having previously observed that risk-models for 90-day outcomes are more robust and discriminate HT recipients better than models for 1-year outcomes. 12, 13 We developed this model within the study cohort rather than applying one of the published models [14] [15] [16] because risk-models perform best within the cohort where they are developed, thereby providing an optimal risk-adjustment tool for the study cohort. We also decided a priori to adjust for the year of transplant in all models because improvement in posttransplant survival over the years has been discernible even after adjusting for baseline patient factors. 7, 8 A lack of association between center case-mix and risk-adjusted survival in the current study suggests that the 90-day risk model provided adequate risk-adjustment.
| Study implications
The finding that center differences in long-term survival can be attributed to mortality within the first 90 days is novel and suggests that improving perioperative management and early posttransplant care at high SMR centers has the highest potential to improve overall HT transplant outcomes. In addition, there are potential implications of this analysis for the SRTR in comparing center outcomes.
Until recently, SRTR has rated centers using a 3-tier system (rated as expected, better, worse) employing measures of standard statistical confidence. 17 As expected statistically, all centers have been found to be "not different" from other centers in most reports, lead- 
| Limitations
This study has limitations. First, this was a retrospective study using registry data with inherent limitations of such data. However, HT in children on a rare basis to improve statistical power, and our findings may not be generalizable to such centers. Third, the OPTN database does not include diagnostic details for patients with congenital heart disease, and the diagnostic characterization we used for risk-adjustment may be an oversimplification.
However, considering the strong performance of the 90-day riskmodel used for risk-adjustment (C-statistic 0.798), it is unlikely that additional knowledge of specific diagnoses will lead to significant model improvement and superior risk-adjustment. Finally, we do not have information on clinical practices-other than avoidance of marginal donors-that allowed low SMR centers to achieve their results. Identifying these factors will require studies using different datasets or a prospective design as well as a willingness by centers to identify and share clinical practices that may explain these outcome differences.
| CON CLUS IONS
In conclusion, there are significant center differences in posttransplant patient and graft survival in currently active pediatric HT centers in the United States. These differences are manifest within the first 90 days posttransplant and are maintained longer term. Identifying clinical practices that allow high-performing centers to achieve superior early results may improve posttransplant survival.
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F I G U R E 4
Percentage of patients and grafts that survived 5-year posttransplant (with 95% confidence intervals) at US pediatric heart transplant centers estimated using the Kaplan-Meier method and stratified by 90-day standardized mortality ratio (SMR quartiles Q1-Q4). Center differences were significant for both (P = .003 for both)
